Back
Stoke Therapeutics Stock Price Chart
Sponsored
STOK
Sponsored
Free Stock Analysis: See What Your Stock is Really Worth
Analyze Any Stock Free
Sell
1
STOK
Stoke Therapeutics
Last Price:
$9.01
Seasonality Move:
15.28%
7 Day Trial
ALL ACCESS PASS
$
7
Free Stock Analysis Report: See The True Value of Any Stock
Analyze Any Stock Free-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and STOK is experiencing slight selling pressure.
Stoke Therapeutics Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 10.62 | Sell |
20-day SMA: | 11.41 | Sell |
50-day SMA: | 12.11 | Sell |
200-day SMA: | 13.17 | Sell |
8-day EMA: | 10.41 | Sell |
20-day EMA: | 11.14 | Sell |
50-day EMA: | 11.88 | Sell |
200-day EMA: | 11.98 | Sell |
Stoke Therapeutics Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.62 | Sell |
Relative Strength Index (14 RSI): | 27.43 | Sell |
Chaikin Money Flow: | -488003 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (10.58 - 12.78) | Sell |
Bollinger Bands (100): | (11.43 - 14.17) | Sell |
Stoke Therapeutics Technical Analysis
Dec 24 | Dec 26 | Dec 27 | Dec 30 | Dec 31 | Jan 2 | Jan 3 | Jan 6 | Jan 7 | Jan 8 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | Jan | |||||||||
24 | 26 | 27 | 30 | 31 | 02 | 03 | 06 | 07 | 08 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Stoke Therapeutics Stock
Is Stoke Therapeutics Stock a Buy?
-
Stoke Therapeutics share price is 8.96 while STOK 8-day simple moving average is 10.62, which is a Sell signal.
-
The stock price of STOK is 8.96 while Stoke Therapeutics 20-day SMA is 11.41, which makes it a Sell.
-
Stoke Therapeutics 50-day simple moving average is 12.11 while STOK share price is 8.96, making it a Sell technically.
-
STOK stock price is 8.96 and Stoke Therapeutics 200-day simple moving average is 13.17, creating a Sell signal.
STOK Technical Analysis vs Fundamental Analysis
Sell
1
Stoke Therapeutics (STOK)
is a Sell
Is Stoke Therapeutics a Buy or a Sell?
-
Stoke Therapeutics stock is rated a SellThe current Stoke Therapeutics [STOK] share price is $8.96. The Score for STOK is 1, which is 98% below its historic median score of 50, and infers higher risk than normal.
Stoke Therapeutics Stock Info
Market Cap:
474.6M
Price in USD:
8.96
Share Volume:
1M
Stoke Therapeutics 52-Week Range
52-Week High:
17.58
52-Week Low:
4.09
Sell
1
Stoke Therapeutics (STOK)
is a Sell
Stoke Therapeutics Share Price Forecast
-
What is the Stoke Therapeutics stock price today?The Stoke Therapeutics stock price is 8.96 USD today.
-
Will STOK stock go up or go down?Stoke Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Stoke Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Stoke Therapeutics is overvalued.
Is Stoke Therapeutics Stock a Buy?
-
Stoke Therapeutics share price is 8.96 while STOK 8-day exponential moving average is 10.41, which is a Sell signal.
-
The stock price of STOK is 8.96 while Stoke Therapeutics 20-day EMA is 11.14, which makes it a Sell.
-
Stoke Therapeutics 50-day exponential moving average is 11.88 while STOK share price is 8.96, making it a Sell technically.
-
STOK stock price is 8.96 and Stoke Therapeutics 200-day simple moving average is 11.98, creating a Sell signal.
Fundamental Analysis of Stoke Therapeutics
Is Stoke Therapeutics a good investment?
-
Analysts estimate an earnings decrease this quarter of $0.15 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.50 per share, and a decrease next year of $0.01 per share.
Technical Analysis of Stoke Therapeutics
Should I short Stoke Therapeutics stock?
-
STOK Moving Average Covergence Divergence (MACD) indicator is -0.62, suggesting Stoke Therapeutics is a Sell
-
Stoke Therapeutics Relative Strength Index (RSI) is 27.43, which suggest Stoke Therapeutics is oversold
-
The Bollinger Bands (25) for Stoke Therapeutics is (10.58 - 12.78), which suggest Stoke Therapeutics is a Sell
-
The Bollinger Bands (100) for Stoke Therapeutics is (11.43 - 14.17), which suggest Stoke Therapeutics is a Sell
* Stoke Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.